CSF3 and neoplasm: Stratified analysis based on BM tumor burden (13% as the cutoff) showed that there were no significant differences in OS between patients who used G-CSF and those did not in both low- and high-BM tumor burden groups, as well as in EFS for patients with high BM tumor burden.